Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Did you mean ertugliflozin pivalate and saxagliptin phosphate?
Displaying drugs 13051 - 13075 of 14390 in total

PA3-17

PA3-17 is CD7-directed chimeric antigen receptor (CAR) T-cell therapy.
Investigational

ETX101

ETX101 is a non-replicating recombinant adeno associated viral vector, serotype 9, designed to promote increased transcription of SCN1A gene.
Investigational

PBGM01

PBGM01 is a non-replicating recombinant adeno-associated virus serotype hu68 vector, which contains human GLB1 transgene encoding the galactosidase beta 1 enzyme.
Investigational

CTR-107

CTR-107 is a synthetic targeted growth factor. It is being investigated for the treatment of familial exudative vitreoretinopathy.
Investigational

Recombinant neuroglobin

Investigational

M1-c6v1

M1-c6v1 is a recombinant oncolytic virus.
Investigational

TSHA-102

TSHA-102 is a recombinant serotype 9 adeno-associated virus encoding a codon-optimized human MECP2 gene.
Investigational

Alpha-1-acid glycoprotein

Investigational

Perenostobart

Perenostobart is an alpha-CD39 IgG4 monoclonal antibody.
Investigational

ECT204

ECT204 is an autologous T-cell therapy whereby T cells are genetically modified to target tumor-specific antigens.
Investigational

Sapablursen

Sapablursen is a synthetic 2'-O-(2-methoxyethyl)-modified antisense oligonucleotide linked to a tri-antennary cluster of N-acetyl galactosamine (GalNAc3) sugars targeting transmembrane protease, serine 6 messenger ribonucleic acid
Investigational

ST266

ST266 is an amniotic membrane-derived cellular cytokine solution.
Investigational

VGB-R04

VGB-R04 is an adeno-associated viral vector delivering human FIX Padua gene.
Investigational

CTX130

CTX130 is an allogeneic CRISPR/Cas9-mediated genetically modified CAR T cell therapy targeting CD70 antigen.
Investigational

Allogeneic natural killer cells

Investigational

AVR-RD-05

AVR-RD-05 is a gene therapy comprising genetically modified autologous stem cells transduced ex vivo with a lentiviral vector encoding the human iduronate-2-sulfatase (IDS) enzyme. It is under investigation for the treatment of Hunter Syndrome (Mucopolysaccharidosis Type II, MPSII).
Investigational

MaaT013

MaaT013 is an allogeneic fecal microbiota therapy. It is being investigated for the treatment of Graft-Versus-Host Disease.
Investigational

ATIR101

ATIR101 is a haploidentical, naïve cell-enriched T-cell therapy.
Investigational

Allogeneic human pancreatic islets of Langerhans

Investigational

ssCART-19 cells

ssCART-19 cells consist of autologous anti-CD19 Chimeric Antigen Receptors (CAR)-T cells expressing a short hairpin RNA (shRNA) against interleukin-6 (IL-6).
Investigational

Epidermal Growth Factor Receptor variant III (EGFRvIII) chimeric antigen receptor T cells

Investigational

Autologous CD4+CD25hiFoxP3+regulatory T cells

Investigational

Avoplacel

Avoplacel (PLX-R18) is an allogeneic cell therapy under investigation for the treatment of acute radiation syndrome.
Investigational

Ex vivo expanded autologous human corneal epithelial cells containing stem cells

Holoclar (ex vivo expanded autologous human corneal epithelial cells containing stem cells) is a stem cell therapy used to treat limbal stem cell deficiencies.
Investigational

Rugonersen

Rugonersen is a locked nucleic acid antisense oligonucleotide under investigation for the treatment of Angelman Syndrome.
Investigational
Displaying drugs 13051 - 13075 of 14390 in total